Letter Agreement Between Meda, Arius, Arius Two and BDSI

EX-10.17 18 dex1017.htm LETTER AGREEMENT BETWEEN MEDA, ARIUS, ARIUS TWO AND BDSI Letter Agreement Between Meda, Arius, Arius Two and BDSI

Exhibit 10.17

August 2, 2006

Meda AB

Box 906

Pipers vag 2A

17009

Solna, Sweden

Attention: Anders Lonners, CEO

Dear Anders:

This letter will confirm our agreement with Meda that neither BDSI, Arius nor Arius Two will take any action to terminate, by mutual agreement with a third party, any agreement which would cause a termination of Meda’s rights under the License and Development Agreement and each document, instrument, agreement, license and/or sublicense related thereto, unless provision is made for Meda’s rights under the License and Development Agreement to continue undisturbed.


Very Truly Yours,

BioDelivery Sciences International, Inc.

By:		/s/ Mark A. Sirgo

Arius Pharmaceuticals, Inc.

By:		/s/ Mark A. Sirgo

Arius Two, Inc.

By:		/s/ Mark A. Sirgo